TRITACE

This brand name is authorized in Austria, Australia, Hong Kong, Croatia, Ireland, Israel, Mexico, Nigeria, Poland, Romania, Singapore, United Kingdom, South Africa

Active ingredients

The drug TRITACE contains one active pharmaceutical ingredient (API):

1 Ramipril UNII L35JN3I7SJ - RAMIPRIL

Ramiprilat, the active metabolite of the prodrug ramipril, inhibits the enzyme dipeptidylcarboxypeptidase I (synonyms: angiotensin-converting enzyme; kininase II). In plasma and tissue this enzyme catalyses the conversion of angiotensin I to the active vasoconstrictor substance angiotensin II, as well as the breakdown of the active vasodilator bradykinin. Reduced angiotensin II formation and inhibition of bradykinin breakdown lead to vasodilatation. Read about Ramipril

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRITACE Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09AA05	Ramipril	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1316G, 1944H, 1945J, 1946K, 8470T
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 136013, 136014, 136015, 13802, 13806, 30401, 337642, 337648, 337650, 337652, 50106, 50109, 50112, 50115
Country: HK	Department of Health Drug Office	Identifier(s): 36855, 36856
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-251741808, HR-H-430835109, HR-H-569874847, HR-H-915616699
Country: IE	Health Products Regulatory Authority	Identifier(s): 48017, 48023, 48042, 48061, 48122, 48166, 48175, 48189
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2658, 2659, 2660
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 040M92
Country: NG	Registered Drug Product Database	Identifier(s): 04-2850, A4-4105
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100093257, 100093263, 100105871, 100403210, 100419078, 100419552, 100423826, 100424889, 100433664, 100447100, 100450128, 100454405, 100456819, 100467064, 100467096, 100468189, 100468437
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W62382001, W62382002, W62382003, W62382004, W62382005, W62382006, W62382007, W62382008, W62382009, W62382010, W62382011, W62382012, W62382013, W62382014, W62382015, W62382016, W62382017, W62382018, W62382019, W62447001, W62447002, W62447003, W62447004, W62447005, W62447006, W62447007, W62447008, W62447009, W62447010, W62447011, W62447012, W62447013, W62447014, W62447015, W62447016, W62447017, W62447018, W62447019, W62447020, W62447021, W62451001, W62451002, W62451003, W62451004, W62451005, W62451006, W62451007, W62451008, W62451009, W62451010, W62451011, W62451012, W62451013, W62451014, W62451015, W62451016, W62451017, W62451018, W62451019
Country: SG	Health Sciences Authority	Identifier(s): 09591P, 09592P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 31/7.1.3/0667, W/7.1.3/235